two were positive for the bla CTX-M-14 gene (Table 1 ). All four bla CTX-M-15 isolates were PCR positive for non-ESBL bla TEM-1 genes. Both bla CTX-M-14 isolates were PCR positive for non-ESBL bla OXA-1 genes, and a single isolate was positive for both bla TEM-1 and bla OXA-1 . By pulsed-field gel electrophoresis (PFGE) analysis, all three S. sonnei and all three S. flexneri isolates demonstrated distinct patterns (data not shown) (15) .
All six bla CTX-M genes were determined to be plasmid encoded (6) . The non-ESBL ␤-lactamases (OXA-1, TEM-1) did not transfer and were not encoded on the same CTX-M plasmids. All three S. sonnei plasmids and two of the S. flexneri plasmids harbored only the CTX-M-associated resistance. The remaining S. flexneri plasmid contained additional determinants conferring resistance to trimethoprim-sulfamethoxazole and gentamicin.
All three S. sonnei plasmids were incompatibility type IncI1 and approximately 90 kb in size (plasmid pulsed-field gel electrophoresis) (Table 1) (4). Plasmid multilocus sequence typing (pMLST) identified them as novel sequence types designated as ST31 complex. The plasmid from AM22451 contained several point mutations in one allele, necessitating the ST32 designation within the ST31 clonal complex (http://pubmlst.org/plasmid) (7). Of the three S. flexneri plasmids, the bla CTX-M-15 -positive plasmid was a 165-kb IncA/C plasmid, while the two bla CTX-M-14 -positive plasmids were identical 75-kb IncFII plasmids. CTX-M-14 and CTX-M-15 are the most common types of cefotaximases identified among Shigella isolates (9, 17, 22) , and IncI1 plas- We thank the NARMS participating public health laboratories for submitting the isolates, Evangeline Sowers for confirming the Shigella species, Anne Whitney for DNA sequencing, Lisa Theobald and the rest of the PulseNet team, and Rebecca Howie for their assistance.
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